儿童肺炎支原体肺炎研究进展(3)
[6] Kannan TR，Provenzano D，Wright JR，et al.Identification and characterization of human surfactant protein A binding protein of Mycoplasma pneumoniae[J].Infect Immun，2005，73(5)：2828-2834.
[7] May M，Papazisi L，Gorton TS，et al.Identification of fibronectin-binding proteins in Mycoplasma gallisepticum strain R[J].Infect Immun，2006，74(3)：1777-1785.
[8] Rhee SG.Cell signaling.H2O2，a necessary evil for cell signaling[J].Science，2006，312(5782)：1882-1883.
[9] Suttorp N，Welte T，Marre R.Community-acquired pneumonia-Preface[M].Birkhauser Advances in Infectious Diseases，2007：Ⅸ，1-25，27-181，183-199，201-245，247-250.
[10] Cartner SC，Lindsey JR，Gibbs-Erwin J，et al.Roles of innate and adaptive immunity in respiratory mycoplasmosis[J].Infect Immun，1998，66(8)：3485-3491.
[11] Hawrylowicz CM，O′Garra A.Potential role of interleukin-10-secreting regulatory T cells in allergy and asthma[J].Nat Rev Immunol，2005，5(4)：271-283.
[12] Henriksson G，Helgeland L，Midtvedt T，et al.Immune response to Mycoplasma pulmonis in nasal mucosa is modulated by the normal microbiota[J].Am J Respir Cell Mol Biol，2004，31(6)：657-662.
[13] 程燕.肺炎支原体感染的免疫反应与临床[J].中国小儿急救医学，2006，13(4)：387-388.
[14] 蔡建敏，周鸿烈，王振海，等.支原体肺炎患儿自然杀伤细胞和细胞毒性T淋巴细胞检测及分析[J].临床儿科杂志，2005，23(10)：721-722.
[15] Narita M，Tanaka H.Cytokines involved in the severe manifestations of pulmonary diseases caused by Mycoplasma pneumoniae[J].Pediatr Pulmonol，2007，42(4)：397.
[16] 常健，赵红霞，鲁继荣，等.不同表现肺炎支原体肺炎患儿血浆白细胞介素-6，8和18水平变化的意义[J].实用临床儿科杂志，2006，21(16)：1062-1063.
[17] Yang J，Hooper WC，Phillips DJ，et al.Regulation of proinflammatory cytokines in human lung epithelial cells infected with Mycoplasma pneumoniae[J].Infect Immun，2002，70(7)：，3649-3655.
[18] Narita M，Tanaka H，Togashi T，et al.Cytokines involved in CNS manifestations caused by Mycoplasma pneumoniae[J].Pediatr Neurol，2005，33(2)：105-109.
[19] Yang J，Hooper WC，Phillips DJ，et al.Cytokines in Mycoplasma pneumoniae infections[J].Cytokine Growth Factor Rev，2004，15(2-3)：157-168.
[20] Wu Q，Martin RJ，Rino JG，et al.IL-23-dependent IL-17 production is essential in neutrophil recruitment and activity in mouse lung defense against respiratory Mycoplasma pneumoniae infection[J].Microbes Infect，2007，9(1)：78-86.
[21] Waites KB，Talkington DF.Mycoplasma pneumoniae and its role as a human pathogen[J].Clin Microbiol Rev，2004，17(4)：697.
[22] Takei T，Morozumi M，Ozaki H，et al.Clinical features of Mycoplasma pneumoniae infections in the 2010 epidemic season：report of two cases with unusual presentations[J].Pediatr Neonatol，2013，54(6)：402-405.
[23] 赵顺英，马云，张桂芳，等.儿童重症肺炎支原体肺炎11例临床分析[J].中国实用儿科杂志，2003，18(7)：414-416.
[24] Lee KY，Lee JS.Immunoglobulin G has a role for systemic protein modulation in vivo：a new concept of protein homeostasis[J].Med Hypotheses，2006，67(4)：845-855.
[25] Tamura A，Matsubara K，Tanaka T，et al.Methylprednisolone pulse therapy for refractory Mycoplasma pneumoniae pneumonia in children[J].J Infect，2008，57(3)：223-228.
[26] 丁圣刚，王建，王亚亭，等.糖皮质激素在治疗儿童重症肺炎支原体肺炎(MPP)中的价值[J].复旦学报(医学版)，2012，39(2)：180-182.
[27] 孟晨.重症支原体肺炎支气管镜下表现与治疗[J].中华儿科杂志，2010，48(12)：954-956.
(收稿日期：2014-05-27 本文编辑：郭静娟) (邱丽筠 郭爱丽 朱薇薇)
[7] May M，Papazisi L，Gorton TS，et al.Identification of fibronectin-binding proteins in Mycoplasma gallisepticum strain R[J].Infect Immun，2006，74(3)：1777-1785.
[8] Rhee SG.Cell signaling.H2O2，a necessary evil for cell signaling[J].Science，2006，312(5782)：1882-1883.
[9] Suttorp N，Welte T，Marre R.Community-acquired pneumonia-Preface[M].Birkhauser Advances in Infectious Diseases，2007：Ⅸ，1-25，27-181，183-199，201-245，247-250.
[10] Cartner SC，Lindsey JR，Gibbs-Erwin J，et al.Roles of innate and adaptive immunity in respiratory mycoplasmosis[J].Infect Immun，1998，66(8)：3485-3491.
[11] Hawrylowicz CM，O′Garra A.Potential role of interleukin-10-secreting regulatory T cells in allergy and asthma[J].Nat Rev Immunol，2005，5(4)：271-283.
[12] Henriksson G，Helgeland L，Midtvedt T，et al.Immune response to Mycoplasma pulmonis in nasal mucosa is modulated by the normal microbiota[J].Am J Respir Cell Mol Biol，2004，31(6)：657-662.
[13] 程燕.肺炎支原体感染的免疫反应与临床[J].中国小儿急救医学，2006，13(4)：387-388.
[14] 蔡建敏，周鸿烈，王振海，等.支原体肺炎患儿自然杀伤细胞和细胞毒性T淋巴细胞检测及分析[J].临床儿科杂志，2005，23(10)：721-722.
[15] Narita M，Tanaka H.Cytokines involved in the severe manifestations of pulmonary diseases caused by Mycoplasma pneumoniae[J].Pediatr Pulmonol，2007，42(4)：397.
[16] 常健，赵红霞，鲁继荣，等.不同表现肺炎支原体肺炎患儿血浆白细胞介素-6，8和18水平变化的意义[J].实用临床儿科杂志，2006，21(16)：1062-1063.
[17] Yang J，Hooper WC，Phillips DJ，et al.Regulation of proinflammatory cytokines in human lung epithelial cells infected with Mycoplasma pneumoniae[J].Infect Immun，2002，70(7)：，3649-3655.
[18] Narita M，Tanaka H，Togashi T，et al.Cytokines involved in CNS manifestations caused by Mycoplasma pneumoniae[J].Pediatr Neurol，2005，33(2)：105-109.
[19] Yang J，Hooper WC，Phillips DJ，et al.Cytokines in Mycoplasma pneumoniae infections[J].Cytokine Growth Factor Rev，2004，15(2-3)：157-168.
[20] Wu Q，Martin RJ，Rino JG，et al.IL-23-dependent IL-17 production is essential in neutrophil recruitment and activity in mouse lung defense against respiratory Mycoplasma pneumoniae infection[J].Microbes Infect，2007，9(1)：78-86.
[21] Waites KB，Talkington DF.Mycoplasma pneumoniae and its role as a human pathogen[J].Clin Microbiol Rev，2004，17(4)：697.
[22] Takei T，Morozumi M，Ozaki H，et al.Clinical features of Mycoplasma pneumoniae infections in the 2010 epidemic season：report of two cases with unusual presentations[J].Pediatr Neonatol，2013，54(6)：402-405.
[23] 赵顺英，马云，张桂芳，等.儿童重症肺炎支原体肺炎11例临床分析[J].中国实用儿科杂志，2003，18(7)：414-416.
[24] Lee KY，Lee JS.Immunoglobulin G has a role for systemic protein modulation in vivo：a new concept of protein homeostasis[J].Med Hypotheses，2006，67(4)：845-855.
[25] Tamura A，Matsubara K，Tanaka T，et al.Methylprednisolone pulse therapy for refractory Mycoplasma pneumoniae pneumonia in children[J].J Infect，2008，57(3)：223-228.
[26] 丁圣刚，王建，王亚亭，等.糖皮质激素在治疗儿童重症肺炎支原体肺炎(MPP)中的价值[J].复旦学报(医学版)，2012，39(2)：180-182.
[27] 孟晨.重症支原体肺炎支气管镜下表现与治疗[J].中华儿科杂志，2010，48(12)：954-956.
(收稿日期：2014-05-27 本文编辑：郭静娟) (邱丽筠 郭爱丽 朱薇薇)